We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $245M
1-Year Est. Return 23.8%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+23.8%
3 Year Est. Return
+70.62%
5 Year Est. Return
+83.19%
10 Year Est. Return
+679.91%
AUM
$164M
AUM Growth
+$14.2M
Cap. Flow
+$5.65M
Cap. Flow %
3.46%
Top 10 Hldgs %
37.6%
Holding
560
New
82
Increased
90
Reduced
94
Closed
59

Top Buys

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$3.09M
2
BIV icon
Vanguard Intermediate-Term Bond ETF
BIV
+$2.32M
3
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$1.46M
4
SCHP icon
Schwab US TIPS ETF
SCHP
+$421K
5
UHS icon
Universal Health Services
UHS
+$414K

Top Sells

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$741K
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$695K
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$525K
4
IWB icon
iShares Russell 1000 ETF
IWB
+$503K
5
SMCI icon
Super Micro Computer
SMCI
+$450K

Sector Composition

Rank Sector Weight
1 Technology 6.37%
2 Healthcare 2.76%
3 Financials 2.76%
4 Communication Services 2.49%
5 Industrials 2.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNDT icon
476
Conduent
CNDT
$238M
$395 ﹤0.01%
+98
New +$360
RXST icon
477
RxSight
RXST
$290M
$395 ﹤0.01%
+8
New +$410
IONQ icon
478
IonQ
IONQ
$18B
$393 ﹤0.01%
45
– –
DAWN
479
DELISTED
Day One Biopharmaceuticals
DAWN
$390 ﹤0.01%
28
– –
NYT icon
480
New York Times
NYT
$10.4B
$390 ﹤0.01%
7
– –
BL icon
481
BlackLine
BL
$1.62B
$386 ﹤0.01%
7
– –
EVER icon
482
EverQuote
EVER
$867M
$380 ﹤0.01%
18
– –
RSKD icon
483
Riskified
RSKD
$771M
$374 ﹤0.01%
79
-684
-90% -$3.74K
STRA icon
484
Strategic Education
STRA
$1.79B
$370 ﹤0.01%
4
– –
BEAM icon
485
Beam Therapeutics
BEAM
$2.77B
$367 ﹤0.01%
15
– –
RNGR icon
486
Ranger Energy Services
RNGR
$401M
$357 ﹤0.01%
+30
New +$347
XENE icon
487
Xenon Pharmaceuticals
XENE
$6.2B
$354 ﹤0.01%
9
– –
MAIN icon
488
Main Street Capital
MAIN
$5.46B
$351 ﹤0.01%
7
– –
ENOV icon
489
Enovis
ENOV
$1.39B
$344 ﹤0.01%
8
– –
CERS icon
490
Cerus
CERS
$524M
$334 ﹤0.01%
192
– –
SSYS icon
491
Stratasys
SSYS
$776M
$332 ﹤0.01%
40
– –
MTLS
492
Materialise
MTLS
$392M
$290 ﹤0.01%
53
– –
NTLA icon
493
Intellia Therapeutics
NTLA
$1.68B
$247 ﹤0.01%
12
-1,697
-99% -$39.1K
FTRE icon
494
Fortrea Holdings
FTRE
$1.75B
$220 ﹤0.01%
11
– –
ML
495
DELISTED
MoneyLion Inc.
ML
$208 ﹤0.01%
5
– –
FATE icon
496
Fate Therapeutics
FATE
$316M
$105 ﹤0.01%
30
– –
DNA icon
497
Ginkgo Bioworks
DNA
$490M
$41 ﹤0.01%
5
-1
-17% -$10
SNEX icon
498
StoneX
SNEX
$8.17B
– –
0
– –
TSP
499
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$16 ﹤0.01%
66
– –
ABNB icon
500
Airbnb
ABNB
$108B
– –
-879
Closed -$133K
18 19
20
21 22

Similar funds

LHCM
Lloyd Harbor Capital Management Cold Spring Harbor, New York $245M AUM 141.83% 1-Year Est. Return
JP
JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return
LC
Longitude (Cayman) Grand Cayman, Cayman Islands $244M AUM
BNMT
Bawa N Mallick Trust Forest Hills, New York $244M AUM 19.8% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return

C.M. Bidwell & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, C.M. Bidwell & Associates held 560 positions worth $164M, up 9.5% from $149M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

C.M. Bidwell & Associates deployed $5.65M of net new capital in Q3 2024, opening 82 new positions and adding to 90 existing holdings. Its largest new stake was Universal Health Services: 1,920 shares worth $440K.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 7.3% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Schwab US Broad Market ETF, an estimated $695K trimmed.

  • C.M. Bidwell & Associates's largest Q3 2024 buy was Universal Health Services: 1,920 shares worth $440K.
  • C.M. Bidwell & Associates added most to Vanguard Short-Term Bond ETF in Q3 2024, an estimated $3.09M increase.
  • C.M. Bidwell & Associates's biggest Q3 2024 reduction was Schwab US Broad Market ETF, cutting an estimated $695K.
  • C.M. Bidwell & Associates fully exited CrowdStrike in Q3 2024, selling an estimated $741K.
  • C.M. Bidwell & Associates's ten largest holdings make up 38% of its $164M portfolio in Q3 2024.
  • C.M. Bidwell & Associates opened 82 new positions and closed 59 in Q3 2024.
  • C.M. Bidwell & Associates's portfolio value rose 9.5% quarter-over-quarter to $164M.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2024, filed 13 Nov 2024.